# OnCo record nct06058377 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06058377/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06058377", "NCT06058377" ;
  schema:name "Durvalumab with chemotherapy in high-risk early breast cancer"@en ;
  schema:alternateName "Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer"@en ;
  schema:description "This study compares usual chemotherapy with or without durvalumab in a selected high-risk group of early breast cancers. It asks whether adding immune treatment lowers the chance of a cancer-related event."@en ;
  schema:url <https://onco.cc/trials/nct06058377/> ;
  schema:dateModified "2026-10-10"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06058377>, <https://clinicaltrials.ucsf.edu/trial/NCT06058377> ;
  onco:status "recruiting" ;
  onco:tag "ucsf-breast-coverage", "interventional" ;
  onco:phase "3" ;
  schema:startDate "2023-11-27" ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/> ;
  onco:drugs <https://onco.cc/drugs/cyclophosphamide/>, <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/durvalumab/>, <https://onco.cc/drugs/paclitaxel/> ;
  onco:institutions <https://onco.cc/institutions/ucsf/> .